7Baggers
Quarterly
Annual
    Unit: USD2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2015-12-31 2014-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31 2008-12-31 2007-12-31 
      
    		                                  
      assets
    		                                  
      current assets:
    		                                  
      cash and cash equivalents
    		1,561,712 768,859 6,452,589 12,687,041 17,788,911 23,849,860 27,612,732 34,676,968 30,902,454 16,257,716 11,423,870 18,107,019 19,538,513 20,842,782 221,807 11,580,594 710,682 283,341 569,359 216,411 175,985 259,701 511,242 190,969 571,154 312,727 1,060,348 1,101,651 1,035,925 1,167,980 1,079,087 3,515,784 2,191,180 1,990,356 
      accounts receivable
    		300,677                                  
      prepaid expenses
    		1,981,134 2,093,519 1,433,153 2,113,249 2,038,283 2,138,971 1,325,998 1,460,207 1,135,780                          
      total current assets
    		3,843,523 2,862,378 7,885,742 14,800,290 19,827,194 25,988,831 28,938,730 36,137,175 32,038,234 16,636,890 11,629,116 18,159,837 19,656,551 20,961,212 810,211 11,734,794 938,315 447,264 795,590 319,796 447,909 619,704 596,187 339,149 802,324 448,074 1,236,975 1,225,495 1,344,474 1,418,003 1,602,192 3,880,720 2,801,834 3,030,814 
      property and equipment
    		170,537 190,113 209,689 212,953 224,080 217,593 234,912 248,983 214,783 206,855 156,938 168,653 149,799 143,224 9,612 10,093 8,618 10,606 9,929 11,827 13,725 11,350 16,270 21,221 26,171 31,151 83,608 96,693 102,486 176,206 248,441 344,202 138,847 75,144 
      other assets
    		81,010 305,691 1,187,788 1,187,788 1,197,788 1,197,788 2,174,286 2,184,286 987,508                  11,010 11,010       
      total assets
    		4,095,070 3,358,182 9,283,219 16,201,031 21,249,062 27,404,212 31,347,928 38,570,444 33,240,525 16,854,755 11,797,064 18,339,500 19,817,360 21,115,446 830,833 11,755,897 957,943 468,880 816,529 342,633 472,644 642,064 623,467 371,380 839,505 490,235 1,331,593 1,333,198 1,477,970 1,645,142 2,357,834 4,315,597 3,056,241 3,246,404 
      liabilities and stockholders’ equity
    		                                  
      current liabilities:
    		                                  
      accounts payable
    		3,983,696 1,883,844 2,802,950 4,213,295 871,131 1,287,995 1,747,682 1,079,421 237,315 426,103 2,057,534 289,438 289,680 232,482 740,829 161,478 91,416 152,653 63,143 116,207 253,166 125,859 147,947 66,032 54,039 77,581 100,935 55,616 163,788 138,339     
      notes payable and accrued interest – related parties
    		142,292                                  
      accrued expenses
    		2,278,308 1,420,063 716,931 2,868,390 3,214,381 3,251,060 3,000,212 3,709,984 3,130,553 3,075,000 3,377,826 46,212 69,342 36,623 1,917,425 579,585 2,076,359 1,851,040 1,732,438 1,510,268 1,378,710 1,238,552 1,149,758 998,062 864,358 733,711 4,055 52,490 33,877 125,869     
      total current liabilities
    		6,404,296 3,303,907 3,519,881 7,081,685 4,085,512 4,539,055 4,747,894 4,789,405 3,367,868 3,501,103 5,435,360 335,650 359,022 451,949 2,670,302 923,647 2,785,865 2,016,193 1,808,081 1,638,975 1,644,376 1,624,831 1,304,999 1,068,262 919,439 811,292 126,990 187,023 327,035 941,535 521,608 571,365 346,422 598,538 
      commitments
    		                                  
      stockholders’ equity
    		                                  
      common stock
    		      26,335    6,382       300           18,733 16,443 15,655 781,628 747,449 731,628 
      authorized shares – 150,000,000 and 600,000,000 at june 30, 2024 and december 31, 2023, respectively
    		                                  
      issued and outstanding shares – 4,178,700 and 1,977,152 at june 30, 2024 and december 31, 2023, respectively
    		4,179                                  
      additional paid-in capital
    		112,964,554 110,265,884 110,125,146 105,864,028 105,499,665 105,273,652 104,970,722 104,767,918 96,901,530 78,147,616 68,731,220 68,630,363 68,134,402 67,937,289 41,189,070 55,203,149 41,658,861 39,340,224 38,818,750 38,165,172 37,898,525 37,264,301 36,830,813 36,558,210 36,219,889 35,589,911 32,587,543 30,823,769 25,587,148 23,319,166 22,105,747 20,500,452 16,215,966 12,441,647 
      accumulated deficit
    		-115,277,959 -110,213,917 -104,363,785 -96,771,377 -88,362,559 -82,434,939 -78,397,023 -73,013,214 -69,045,112 -66,803,413 -64,375,898 -50,632,895 -48,682,392 -47,368,359 -43,443,207 -44,469,059 -43,898,411 -42,847,513 -42,256,920 -41,832,486 -41,178,338 -40,476,884 -39,842,539 -39,175,646 -38,538,603 -37,916,790 -32,474,927 -29,785,640       
      total stockholders’ equity
    		-2,309,226 54,275 5,763,338 9,119,346 17,163,550 22,865,157 26,600,034 31,781,039 27,872,657 11,353,652 4,361,704 18,003,850 19,458,338 20,651,340 -1,864,250 10,813,744 -1,849,621 -1,574,556 -1,020,719 -1,328,633 -1,207,149 -1,022,347 -724,238 -742,714 -128,892 -321,057 1,204,603 1,146,175 1,150,935 703,607 1,836,226 3,744,232 2,709,819 2,647,866 
      total liabilities and stockholders’ equity
    		4,095,070 3,358,182 9,283,219 16,201,031 21,249,062 27,404,212 31,347,928 38,570,444 33,240,525 16,854,755 11,797,064 18,339,500 19,817,360 21,115,446 830,833 11,755,897 957,943 468,880 816,529 342,633 472,644 642,064 623,467 371,380 839,505 490,235 1,331,593 1,333,198 1,477,970 1,645,142 2,357,834 4,315,597 3,056,241 3,246,404 
      stockholders’ equity:
    		                                  
      authorized shares – 150,000,000 and 600,000,000 at march 31, 2024 and december 31, 2023, respectively
    		                                  
      issued and outstanding shares – 2,308,309 and 1,977,152 at march 31, 2024 and december 31, 2023, respectively
    		 2,308                                 
      authorized shares – 600,000,000
    		                                  
      issued and outstanding shares – 1,977,152 and 1,755,664 at december 31, 2023 and 2022, respectively
    		  1,977                                
      issued and outstanding shares – 26,695,287 and 26,334,953 at september 30, 2023 and december 31, 2022, respectively
    		   26,695                               
      issued and outstanding shares – 26,443,649 and 26,334,953 at june 30, 2023 and december 31, 2022, respectively
    		    26,444                              
      authorized shares – 600,000,000 issued and outstanding shares – 26,443,649 and 26,334,953 at march 31, 2023 and december 31, 2022, respectively
    		     26,444                             
      grant funds receivable
    		                         59,758 119,978 79,341 266,248 183,515 474,275 320,321 311,368 93,260 
      other liabilities
    		       2,000,000 2,000,000                          
      total liabilities
    		      4,747,894 6,789,405 5,367,868 5,501,103 7,435,360 335,650 359,022 464,106 2,695,083 942,153 2,807,564 2,043,436 1,837,248 1,671,266 1,679,793 1,664,411 1,347,705 1,114,094 968,397          
      authorized shares – 600,000,000 issued and outstanding shares – 26,334,953 and 6,381,541 at september 30, 2022 and december 31, 2021, respectively
    		       26,335                           
      authorized shares – 600,000,000 issued and outstanding shares – 16,238,739 and 6,381,541 at june 30, 2022 and december 31, 2021, respectively
    		        16,239                          
      grant funds and other receivables
    		         99,526 49,006    520,509 141,154 187,163 68,603 103,485 64,246 160,277 121,814 14,757  5,000          
      prepaid expenses and other current assets
    		         279,648 156,240 52,818 118,038 118,430 67,895 13,046 40,470 95,320 122,746 39,139 111,647 238,189 70,188 148,180 226,170 75,589 56,649 44,503 42,301 66,508     
      deposits
    		         11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010 11,010       980 980 
      accrued expenses - noncurrent
    		         2,000,000                         
      authorized shares – 600,000,000 issued and outstanding shares – 9,449,025 and 6,381,541 at march 31, 2022 and december 31, 2021, respectively
    		         9,449                         
      current portion of notes payable
    		             182,844 12,048 182,584 182,379 12,500 12,500 12,500 12,500 260,420             
      accrued expenses – noncurrent
    		          2,000,000                        
      note payable, net of current portion
    		             12,157 24,781 18,506 21,699 27,243 29,167 32,291 35,417 39,580 42,706 45,832 48,958          
      preferred stock, .01 par value: authorized shares – 10,000,000 series b convertible preferred stock, 1,000 stated value; -0- and 100 shares issued and outstanding at december 31, 2021 and 2020, respectively
    		                                  
      preferred stock, .01 par value:
    		                                  
      authorized shares – 10,000,000 series b convertible preferred stock, 1,000 stated value; -0- and 100 shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively
    		                                  
      authorized shares – 600,000,000 issued and outstanding shares – 6,381,541 and 3,834,095 at september 30, 2021 and december 31, 2020, respectively
    		           6,382                       
      authorized shares – 10,000,000
    		                                  
      series b convertible preferred stock, 1,000 stated value; -0- and 100 shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively
    		                                  
      issued and outstanding shares – 6,327,702 and 3,834,095 at june 30, 2021 and december 31, 2020, respectively
    		            6,328                      
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively
    		             76,095                     
      issued and outstanding shares – 6,315,467 and 3,834,095 at march 31, 2021 and december 31, 2020, respectively
    		             6,315                     
      preferred stock, .01 par value
    		                                  
      issued and outstanding shares – 400 and 2,486 march 31, 2020 and december 31, 2019, respectively
    		              376,095                    
      issued and outstanding shares – 13,791,601 and 299,835 at march 31, 2020 and december 31, 2019, respectively
    		              13,792                    
      issued and outstanding shares – 100 and 2,486 september 30, 2020 and december 31, 2019, respectively
    		               76,095                   
      issued and outstanding shares – 3,559,473 and 14,992 at september 30, 2020 and december 31, 2019, respectively
    		               3,559                   
      convertible debentures
    		                435,711                  
      issued and outstanding shares – 400 and 2,486 june 30, 2020 and december 31, 2019, respectively
    		                376,095                  
      issued and outstanding shares – 13,834,075 and 299,835 at june 30, 2020 and december 31, 2019, respectively
    		                13,834                  
      preferred stock, .01 par value (note 7): authorized shares – 10,000,000 issued and outstanding shares – 2,486 and 3,450 at december 31, 2019 and 2018, respectively
    		                 1,932,433                 
      issued and outstanding shares – 3,054 and 3,450 september 30, 2019 and december 31, 2018, respectively
    		                  2,321,823                
      issued and outstanding shares – 95,627,584 and 437,807 at september 30, 2019 and december 31, 2018, respectively
    		                  95,628                
      issued and outstanding shares – 3,402 and 3,450 at june 30, 2019 and december 31, 2018, respectively
    		                   2,337,867               
      issued and outstanding shares – 813,916 and 437,807 at june 30, 2019 and december 31, 2018, respectively
    		                   814               
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at march 31, 2019 and december 31, 2018
    		                    76,095              
      series c convertible preferred stock, 1,000 stated value; -0- and 2,150 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                                  
      series e convertible preferred stock, 1,000 stated value; -0- and 1,200 shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                                  
      series f convertible preferred stock, 1,000 stated value; 2,583 and -0- shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                    1,591,763              
      series g convertible preferred stock, 1,000 stated value; 500 and -0- shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively
    		                    404,250              
      issued and outstanding shares – 556,489 and 437,807 at march 31, 2019 and december 31, 2018, respectively
    		                    556              
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at december 31, 2018 and 2017
    		                     76,095             
      series c convertible preferred stock, 1,000 stated value; 2,150 and 2,570 shares issued and outstanding at december 31, 2018 and 2017, respectively
    		                     705,238             
      series d convertible preferred stock, 1,000 stated value; -0- and 1,000 shares issued and outstanding at december 31, 2018 and 2017, respectively
    		                                  
      series e convertible preferred stock, 1,000 stated value; 1,200 and -0- shares issued and outstanding at december 31, 2018 and 2017, respectively
    		                     1,190,000             
      issued and outstanding shares – 218,903,476 and 106,736,810 at december 31, 2018 and 2017, respectively
    		                     218,903             
      current portion of note payable
    		                      7,294 4,168 1,042          
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at september 30, 2018 and december 31, 2017
    		                      76,095            
      series c convertible preferred stock, 1,000 stated value; 2,570 shares issued and outstanding at september 30, 2018 and december 31, 2017
    		                      842,990            
      series d convertible preferred stock, 1,000 stated value; -0- and 1,000 shares issued and outstanding at september 30, 2018 and december 31, 2017
    		                                  
      series e convertible preferred stock, 1,000 stated value; 1,200 and -0- shares issued and outstanding at september 30, 2018 and december 31, 2017
    		                      1,190,000            
      issued and outstanding shares – 178,403,476 and 106,736,810 at september 30, 2018 and december 31, 2017
    		                      178,403            
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at june 30, 2018 and december 31, 2017
    		                       76,095           
      series c convertible preferred stock, 1,000 stated value; 2,570 shares issued and outstanding at june 30, 2018 and december 31, 2017
    		                       842,990           
      series d convertible preferred stock, 1,000 stated value; 205 and 1,000 shares issued and outstanding at june 30, 2018 and december 31, 2017
    		                       200,900           
      series e convertible preferred stock, 1,000 stated value; 600 and -0- shares issued and outstanding at june 30, 2018 and december 31, 2017
    		                       590,000           
      issued and outstanding shares – 164,736,810 and 106,736,810 at june 30, 2018 and december 31, 2017
    		                       164,737           
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at march 31, 2018 and december 31, 2017
    		                        76,095          
      series c convertible preferred stock, 1,000 stated value; 2,570 shares issued and outstanding at march 31, 2018 and december 31, 2017
    		                        842,990          
      series d convertible preferred stock, 1,000 stated value; 550 and 1,000 shares issued and outstanding at march 31, 2018 and december 31, 2017
    		                        539,000          
      series e convertible preferred stock, 1,000 stated value; 600 and -0- shares issued and outstanding at march 31, 2018 and december 31, 2017
    		                        590,000          
      authorized shares – 600,000,000 issued and outstanding shares – 141,736,810 and 106,736,810 at march 31, 2018 and december 31, 2017
    		                        141,737          
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at december 31, 2017 and 2016, respectively
    		                         76,095         
      series c convertible preferred stock, 1,000 stated value; 2,570 and 2,868 shares issued and outstanding at december 31, 2017 and 2016, respectively
    		                         842,990         
      series d convertible preferred stock, 1,000 stated value; 1,000 and -0- shares issued and outstanding at december 31, 2017 and 2016, respectively
    		                         980,000         
      authorized shares – 600,000,000 and 300,000,000 at december 31, 2017 and 2016, respectively
    		                                  
      issued and outstanding shares – 106,736,810 and 55,235,233 at december 31, 2017 and 2016, respectively
    		                         106,737         
      amounts due to emory university
    		                          22,000        
      series b convertible preferred stock, 1,000 stated value; 100 shares issued and outstanding at december 31, 2015 and 2014, respectively
    		                          76,095        
      series c convertible preferred stock, 1,000 stated value; 3,000 and -0- shares issued and outstanding at december 31, 2015 and 2014, respectively
    		                          983,941        
      authorized shares – 150,000,000 and 75,000,000 at december 31, 2015 and 2014, respectfully
    		                                  
      issued and outstanding shares – 31,950,813 at december 31, 2015 and 2014, respectively
    		                          31,951        
      amounts payable to emory university
    		                           78,917 129,370 677,327 182,980 163,021  156,225 
      series a convertible preferred stock, 1,000 stated value; -0- and 71 shares issued and outstanding at december 31, 2014 and 2013, respectively
    		                                  
      series b convertible preferred stock, 1,000 stated value; 100 and 1,650 shares issued and outstanding at december 31, 2014 and 2013, respectively
    		                           76,095       
      authorized shares – 75,000,000
    		                                  
      issued and outstanding shares – 31,950,813 and 23,765,180 at december 31, 2014 and 2013, respectively
    		                           31,951       
      other assets:
    		                                  
      licenses, net of accumulated amortization of 228,856 and 208,933 at december 31, 2012 and 2011 respectively
    		                            20,000      
      deposits and other assets
    		                            11,010 11,010     
      total other assets
    		                            31,010 50,933 507,201 90,675 115,560 140,446 
      preferred stock, .01 par value, 10,000,000 shares authorized; series a convertible preferred stock, 1,000 stated value; 788 and -0- shares issued and outstanding at december 31, 2012 and december 31, 2011, respectively
    		                            312,196      
      deficit accumulated during the development stage
    		                            -24,767,142 -22,632,002 -20,285,176 -17,537,848 -14,253,596 -10,525,409 
      licenses, net of accumulated amortization of 208,933 and 184,047 at december 31, 2011 and 2010 respectively
    		                             39,923     
      deferred offering costs
    		                              430,402    
      prepaid expenses and other
    		                              48,830 44,615 299,286 49,748 
      licenses, net of accumulated amortization of 184,047 and 159,161 at december 31, 2010 and 2009 respectively
    		                              64,809    
      deposits and other
    		                              11,990 980   
      accounts payable and accrued expenses
    		                              338,628 408,344 176,260 390,993 
      licenses, net of accumulated amortization of 159,161 and 134,276
    		                                  
      at december 31, 2009 and 2008 respectively
    		                               89,695   
      stock subscriptions receivable
    		                                 897,450 
      licenses, net of accumulated amortization of 134,276 and 109,390 at december 31, 2008 and 2007, respectively
    		                                114,580  
      amounts payable to related parties
    		                                170,162  
      accrued salaries
    		                                 51,320 
      licenses, net of accumulated amortization of 109,390 and 84,504 at december 31, 2007 and 2006, respectively
    		                                 139,466 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.